Search Results - "Loussouarn, D"

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis by Hinsinger, G, Galéotti, N, Nabholz, N, Urbach, S, Rigau, V, Demattei, C, Lehmann, S, Camu, W, Labauge, P, Castelnovo, G, Brassat, D, Loussouarn, D, Salou, M, Laplaud, D, Casez, O, Bockaert, J, Marin, P, Thouvenot, E

“…Background: Despite sensitivity of MRI to diagnose multiple sclerosis (MS), prognostic biomarkers are still needed for optimized treatment. Objective: The…”
Get full text

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers by Louault, K., Bonneaud, T. L, Séveno, C., Gomez-Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé-Nion, S., Jézéquel, P., Campone, M., Amiot, M., Juin, P. P., Souazé, F.

“…Selective inhibition of BCL-2 is expected to enhance therapeutic vulnerability in luminal estrogen receptor-positive breast cancers. We show here that the…”
Get full text

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation by Poetsch, L., Bronnimann, C., Loiseau, H., Frénel, J. S., Siegfried, A., Seizeur, R., Gauchotte, G., Cappellen, D., Carpentier, C., Figarella-Branger, D., Eimer, S., Meyronet, D., Ducray, F.

“…Background Approximately 10% of IDH -mutant gliomas harbour non-canonical IDH mutations (non- p.R132H IDH1  and IDH2 mutations). Objective The aim of this…”
Get full text

Masson's tumor revealed by an intracerebral hematoma. Case report and a review of the literature by Salaud, C., Loussouarn, D., Buffenoir, K., Riem, T.

“…We report the case of a 56-year-old woman who underwent total resection of a Masson's tumor or intravascular papillary endothelial hyperplasia (IPEH), which…”
Get full text

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer by Loussouarn, D, Campion, L, Leclair, F, Campone, M, Charbonnel, C, Ricolleau, G, Gouraud, W, Bataille, R, Jézéquel, P

“…Background: We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The…”
Get full text

Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience by Frenel, J. S., Leux, C., Loussouarn, D., Le Loupp, A.-G., Leclair, F., Aumont, M., Mervoyer, A., Martin, S., Denis, M. G., Campone, M.

“…IDH1/2 mutations and 1p/19q codeletion occur frequently in anaplastic gliomas and are prognostic factors. We combined these two biomarkers to stratify patients…”
Get full text

Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series by Castelli, J., Feuvret, L., Haoming, Q. C., Biau, J., Jouglar, E., Berger, A., Truc, G., Gutierrez, F. Llamas, Morandi, X., Le Reste, P. J., Thillays, F., Loussouarn, D., Nouhaud, E., Crehange, G., Antoni, D., Vauleon, E., de Crevoisier, R., Noel, G.

“…The aims of this multicentre retrospective study were to identify prognostic or therapeutic factors impacting on overall survival in patients with gliosarcoma…”
Get full text

Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme by Cartron, P F, Loussouarn, D, Campone, M, Martin, S A, Vallette, F M

“…Apoptosis has a crucial role in anti-cancer treatment. The proteins of the BCL-2 family are core members of the apoptotic program. Thus, we postulated that…”
Get full text

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas by Loussouarn, D, Campion, L, Sagan, C, Frenel, J-S, Dravet, F, Classe, J-M, Pioud-Martigny, R, Berton-Rigaud, D, Bourbouloux, E, Mosnier, J-F, Bataille, F-R, Campone, M

“…Carcinoma cells lack syndecan-1 expression when they are transiting from an epithelial to a less-differentiated mesenchymal phenotype (epithelial–mesenchymal…”
Get full text

Magnetic Resonance Imaging for local preoperative staging in endometrial cancer: Nantes local experience by Coussoou, C, Laigle-Quérat, V, Loussouarn, D, Vaucel, E, Frampas, E

“…To determine the diagnostic accuracy of magnetic resonance imaging (MRI) for local preoperative staging in endometrial cancer in our center (Centre Hospitalier…”
Get full text

Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma by Doucet, L., Cailleteau, A., Vaugier, L., Gourmelon, C., Bureau, M., Salaud, C., Roualdes, V., Samarut, E., Aumont, M., Zenatri, M., Loussouarn, D., Quillien, V., Bocquet, F., Payen-Gay, L., Joubert, D., Prieur, A., Robert, M., Frenel, J.-S.

“…Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG80, is a…”
Get full text

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas by Appay, Romain, Tabouret, Emeline, Macagno, Nicolas, Touat, Mehdi, Carpentier, Catherine, Colin, Carole, Ducray, François, Idbaih, Ahmed, Mokhtari, Karima, Uro-Coste, Emmanuelle, Dehais, Caroline, Figarella-Branger, Dominique

“…716 IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas Diffuse gliomas are classified according to the 2016 World Health…”
Get full text

PO-0661: Gliosarcoma: prognostic and therapeutics factors by Castelli, J, Feuvret, L, Haoming, Q, Biau, J, Jouglar, E, Berger, A, Truc, G, Guttierrez, F. Llama, Morandi, X, Thillays, F, Loussouarn, D, Lecouillard, I, Crehange, G, Antoni, D, Vauleon, E, De Crevoisier, R, Noë, G

Get full text

Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme by LALIER, L, CARTRON, P.-F, PEDELABORDE, F, OLIVIER, C, LOUSSOUARN, D, MARTIN, S. A, MEFLAH, K, MENANTEAU, J, VALLETTE, F. M

“…Prostaglandin E(2) plays multiple roles both in the physiology and the physiopathology of human brain, which are not completely understood. We have identified…”
Get full text

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas by Grandin, Nathalie, Pereira, Bruno, Cohen, Camille, Billard, Pauline, Dehais, Caroline, Carpentier, Catherine, Idbaih, Ahmed, Bielle, Franck, Ducray, François, Figarella-Branger, Dominique, Delattre, Jean-Yves, Sanson, Marc, Lomonte, Patrick, Poncet, Delphine, Verrelle, Pierre, Charbonneau, Michel

“…All cancer cells need to maintain functional telomeres to sustain continuous cell division and proliferation. In human diffuse gliomas, functional telomeres…”
Get full text

P17.03 POST-OPERATIVE EXCLUSIVE CHEMOTHERAPY WITH PCV FOR ANAPLASTIC OLIGODENDROGLIOMA: A RETROSPECTIVE STUDY OF 35 CONFIRMED CASES by Augereau, P., Rousseau, A., Michalak, S., Pavageau, A., Loussouarn, D., Jadaud, E., Nader, E., Menei, P., Soulie, P.

“…INTRODUCTION: Anaplastic oligodendroglioma/oligoastrocytoma (AO/AOA) represent among primary brain tumors a distinct chemosensitive heterogeneous entity with…”
Get full text

6141 POSTER Frequent Molecular Alterations in Brain Metastases From Colorectal Tumours by Denis, M, Loussouarn, D, Theoleyre, S, Vansteene, D, Bennouna, J

Get full text

Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index by Bossard, C, Jarry, A, Colombeix, C, Bach-Ngohou, K, Moreau, A, Loussouarn, D, Mosnier, J-F, Laboisse, C L

“…Background: Microscopic evaluation of mitotic figures is a routine procedure in the assessment of the histoprognostic grade of tumours. Nevertheless, their…”
Get full text

An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma by Hervier, B, Latour, S, Loussouarn, D, Rimbert, M, De-Saint-Basile, G, Picard, C, Hamidou, M

“…Abstract X-linked lymphoproliferative disease (XLP) is an inherited immunodeficiency, partially characterized by a defect in cytotoxicity to Epstein-Barr…”
Get full text

Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: A retrospective study of 108 cases by Classe, J.M, Jaffre, I, Frenel, J.S, Bordes, V, Dejode, M, Dravet, F, Ferron, G, Marchal, F, Berton Rigaud, D, Loussouarn, D, Campion, L

“…Abstract Aims To determine overall survival of patients treated for a first relapse of FIGO stage III ovarian cancer, outside of randomized trial, with a long…”
Get full text